As of 10 December 2020, the total IPO fundraising volume for the year already represented an increase compared to 2019, with a 25 per cent rise recorded year-over-year. The listings under the pre-revenue biotech chapter had also experienced substantial growth with 26 new listings in 2020, raising a total of HKD70.7 billion since the launch in 2018 of the new listing regime which allows companies in emerging and innovative sectors and pre-revenue biotech companies seeking to list to make formal application.

We observed a shift in the focus of the market where the new economy companies had taken centre stage.  As of 10 December 2020, they accounted for close to 60 per cent of IPO funds raised in Hong Kong since the new listing rules took effect. The average daily turnover contribution from the new economy companies listed since 2018 in the cash equities market had also increased from 4.1 per cent in 2018 to 22.8 per cent in November 2020.  Hong Kong has now become the world’s second largest biotech fundraising hub, ushering in 47 healthcare and biotech listings to the Stock Exchange Main Board since the launch of the new listing regime.

In October 2020, the Stock Exchange published its consultation conclusions on corporate weighted voting rights (WVR) companies.  The Stock Exchange decided not to implement the proposals set out in the consultation paper, giving the market more time to develop a better understanding of the proposed regulatory approach towards regulating listed companies with WVR structures and their controllers.  However, the Stock Exchange did decide to extend the grandfathering arrangements to enable qualifying issuers with corporate WVR to seek secondary listings in Hong Kong.

While it appears that the Hong Kong stock market will not be seeing new listings with corporate WVR structures in the near future, the extension of the grandfathering arrangement is said to be paving the way for more Greater China companies to seek secondary listings in Hong Kong, especially technology companies currently facing closer scrutiny as Sino-US tension heightens.

Type

Insight

Locations

Hong Kong

Share
Twitter LinkedIn Email Save as PDF
More Publications
27 Sep 2022

The fork in the privatization road

With the likelihood of recession and an increase in interest rates facing some economies and ongoing...

27 Sep 2022

Resealing Hong Kong Grants of Probate in the BVI

Once resealed, grants obtained in Hong Kong shall have the same force and effect, and have the same ...

Contributors: Crystal Au-Yeung
27 Sep 2022

Can We Eventually Agree on Whether and How to Take Security over Digital Assets?

Innovative technology in China has made a spurt of progress in recent years.

27 Sep 2022

Similar but Different

While the basic features of the trust remain, there are some notable differences in how trusts can b...

27 Sep 2022

Updates on Bermuda Economic Substance Requirements

The Bermuda Registrar of Companies (ROC) extended the filing deadline for those entities which earne...

27 Sep 2022

Prelude to China's 20th National Congress

The 20th National Congress of the Chinese Communist Party, to be convened in the second half of 2022...

Contributors: Angelina Wong
30 Aug 2022

The Cayman Islands restructuring officer regime comes into force on 31 August 2022

These new proceedings will significantly enhance the Cayman Islands restructuring regime.

28 Apr 2022

The New Era of China’s Belt and Road Initiative

It presents new opportunities for the offshore legal space, from the establishment of offshore inves...

Contributors: Angelina Wong
28 Apr 2022

Restructuring the offshore debt of Chinese Real Estate Developers

This article sets out how the current regimes in the Cayman Islands and the BVI can assist with rest...

Contributors: Crystal Au-Yeung
28 Apr 2022

Assignment, novation or sub-participation of loans             

Transfers of loan portfolios between lending institutions have always been commonplace in the financ...